You have 9 free searches left this month | for more free features.

Biliary Tract Neoplasms

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

Not yet recruiting
  • Biliary Tract Neoplasms
  • Total Neoadjuvant Treatment
  • (no location specified)
Sep 7, 2023

Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)

Not yet recruiting
  • Biliary Tract Diseases
  • +5 more
  • no interventions
  • (no location specified)
Jun 1, 2023

Biliary Tract Tumors, Immunotherapy Trial in Beijing (Durvalumab, Lenvatinib Oral Product, Chemotherapy)

Recruiting
  • Biliary Tract Neoplasms
  • Immunotherapy
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Jul 6, 2023

Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)

Active, not recruiting
  • Biliary Tract Neoplasms
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 30, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

LIver, Biliary tRAct and pancReatic Cancers

Recruiting
  • Liver Cancer
  • +2 more
  • Blood drawing
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital, Zhejiang University School of Me
Nov 14, 2023

Observational Monocentric Study on Biliary Tract Cancer (BABEL)

Recruiting
  • Biliary Tract Cancer
    • Roma, Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli/IRCSS - UO
    Jul 10, 2023

    Advanced Biliary Tract Cancer Trial (H101, Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Advanced Biliary Tract Cancer
    • (no location specified)
    Apr 11, 2023

    Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -

    Not yet recruiting
    • Biliary Tract Cancer
      • (no location specified)
      Apr 26, 2023

      Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

      Not yet recruiting
      • Biliary Tract Cancer
      • (no location specified)
      Aug 16, 2023

      Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)

      Not yet recruiting
      • Advanced Biliary Tract Cancer
      • Tianjin, Tianjin, China
        Tianjin Cancer Hospital Airport Hospital
      Apr 7, 2023

      European Training Program for Robotic Liver Surgery (LIVEROBOT)

      Not yet recruiting
      • Liver Diseases
      • +6 more
      • European Multicentre Training Program for Robotic Liver Surgery
      • (no location specified)
      Feb 8, 2023

      Trace Element Deficiency Trial in Ljubljana (trace elements)

      Recruiting
      • Trace Element Deficiency
      • trace elements
      • Ljubljana, Slovenia
        Institute of Oncology Ljubljana
      Sep 27, 2023

      Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)

      Not yet recruiting
      • Advanced Biliary Tract Cancer
      • (no location specified)
      Apr 2, 2023

      Postoperative Recurrence in Biliary Tract Cancers:A Multicenter

      Recruiting
      • Biliary Tract Cancer
      • No intervention
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with NanJing Medical University
      Feb 15, 2023

      Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

      Not yet recruiting
      • Pancreatic Cancer
      • Baltimore, Maryland
        SKCCC Johns Hopkins
      Aug 16, 2023

      Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

      Recruiting
      • Advanced Biliary Tract Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 22, 2023

      Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

      Recruiting
      • Biliary Tract Cancer
      • +2 more
      • Immune Checkpoint Inhibitors
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Oct 5, 2023

      Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

      Not yet recruiting
      • Biliary Tract Carcinoma
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin
      Sep 15, 2023

      Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

      Recruiting
      • Biliary Tract Cancer
      • +2 more
      • Tumor Infiltrating Lymphocytes (TIL)
      • Pittsburgh, Pennsylvania
        Allyson Welsch
      Jul 21, 2022

      HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)

      Not yet recruiting
      • HER2-positive Colorectal Cancer
      • HER2-positive Biliary Tract Cancer
      • Beijing, State*, China
        Peking University cancer hospital & institution
      Aug 2, 2023

      Biliary Tract Cancers Trial (durvalumab)

      Not yet recruiting
      • Biliary Tract Cancers
      • (no location specified)
      Jun 20, 2023

      Advanced Biliary Tract Cancer Trial in Changsha (IBI310, sintilimab)

      Not yet recruiting
      • Advanced Biliary Tract Cancer
      • Changsha, Hunan, China
        Hunan cancer Hospital
      Dec 13, 2022

      AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary

      Recruiting
      • Biliary Tract Cancer
      • Blood drawing
      • Guangzhou, Guangdong, China
      • +1 more
      Dec 28, 2022

      Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)

      Recruiting
      • Biliary Tract Cancer
      • Tumour and germline molecular profiling
      • MontrĂ©al, Quebec, Canada
        McGill University Health Centre
      Nov 2, 2022